Medical AI company Mediwhale is accelerating its push into the global digital healthcare market with its AI-powered retinal analysis technology. The company is strengthening its presence by securing additional European medical device certification fo
Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis
SK Bioscience Opens Songdo Headquarters to Families as It Expands Employee-Centered Corporate Culture

SK Bioscience Opens Songdo Headquarters to Families as It Expands Employee-Centered Corporate Culture

SK Bioscience said on June 1 that it recently hosted a family open house event, titled “SK Scientist Family Housewarming,” at its headquarters in Songdo, Incheon. More than 450 employees and family members attended the event. The gathering marked the
3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

3billion Launches Genome-Based Newborn Screening Service Overseas to Expand Early Genetic Diagnosis

AI-powered rare disease diagnostics company 3billion (394800) announced on June 1 the official launch of 3B-NEO, a genome-based newborn screening service. 3B-NEO is a genomic newborn screening (gNBS) service designed to identify the risk of genetic d
Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical announced on June 1 that it recently signed a memorandum of understanding (MOU) with biotechnology company Aribio Lab to establish a strategic partnership for the joint development and commercialization of vaccines. Under the ag
Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics said its gastroesophageal disease treatment Zaqbo has entered a Phase 3 clinical trial in China for an additional indication as a treatment for Helicobacter pylori eradication. The company said on May 29 that its Chinese partner
Seoul St. Mary’s Hospital Performs Korea’s First Single-Port Robotic Surgery for Plantar Hyperhidrosis

Seoul St. Mary’s Hospital Performs Korea’s First Single-Port Robotic Surgery for Plantar Hyperhidrosis

Seoul St. Mary's Hospital said it has successfully performed robotic surgery for hyperhidrosis using a single-port robotic platform. The hospital said on May 29 that a team led by Bang Seok-hwan from the Department of Urology successfully treated pla
Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion said on May 29 that it has entered the final stage of preclinical development for global clinical trials of its next-generation obesity treatment candidate CT-G32 by launching primate toxicology studies. The company aims to submit an invest
Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of the cardiovascular department at Seoul St. Mary's Hospital has been selected as the only researcher in the applied medical sciences field for the Ministry of Science and ICT’s “Basic Research Program Leader Researcher” initiative
Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

Researchers Identify Bone Age Differences Between Limbs in Rare Pediatric Overgrowth Disorders

Children with congenital hemihypertrophy — a condition in which one side of the body grows larger than the other — may not only have differences in limb length, but also differences in the rate of bone maturation, with longer bones potentially finish
HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB is set to participate in the world's largest cancer conference, the American Society of Clinical Oncology (ASCO 2026), opening on May 29. The company will operate a standalone booth to share clinical data and treatment strategies for its liver an

© Copyright by News1. All Rights Reserved.